Cosmetic composition for slimming containing L-arginine, an L-arginine analogue, or one of their derivatives, for topical application
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-006/00
A61K-009/127
A61K-038/00
A61K-031/21
A61K-031/04
출원번호
US-0596079
(2000-06-16)
우선권정보
FR-0007631 (1999-06-16)
발명자
/ 주소
Seguin, Marie-Christine
출원인 / 주소
Exsymol S.A.M.
대리인 / 주소
Lydon, James C.
인용정보
피인용 횟수 :
20인용 특허 :
12
초록▼
A cosmetic composition for slimming which includes, in combination with a cosmetically acceptable excipient, at least one compound having the formula (I) where R1is a group bound by a peptidic bond and selected from the group consisting of a hydrogen atom, a hydroxyl group, an acyl group, acylox
A cosmetic composition for slimming which includes, in combination with a cosmetically acceptable excipient, at least one compound having the formula (I) where R1is a group bound by a peptidic bond and selected from the group consisting of a hydrogen atom, a hydroxyl group, an acyl group, acyloxy group and a substituted or unsubstituted aminoacid; R2is a group bond by a peptidic bond and selected from the group consisting of a hydroxyl group, an amine group, an alkoxy group, an alkylamine group, a silyloxy group or a substituted or unsubstituted aminoacid; and n is 3 or 4.
대표청구항▼
A cosmetic composition for slimming which includes, in combination with a cosmetically acceptable excipient, at least one compound having the formula (I) where R1is a group bound by a peptidic bond and selected from the group consisting of a hydrogen atom, a hydroxyl group, an acyl group, acylox
A cosmetic composition for slimming which includes, in combination with a cosmetically acceptable excipient, at least one compound having the formula (I) where R1is a group bound by a peptidic bond and selected from the group consisting of a hydrogen atom, a hydroxyl group, an acyl group, acyloxy group and a substituted or unsubstituted aminoacid; R2is a group bond by a peptidic bond and selected from the group consisting of a hydroxyl group, an amine group, an alkoxy group, an alkylamine group, a silyloxy group or a substituted or unsubstituted aminoacid; and n is 3 or 4. coccal M Protein," The Journal Of Biological Chemistry 255(13):6284-6289, 1980. Beachey et al., "Protective Immunogenicity And T Lymphocyte Specificity Of A Trivalent Hybrid Peptide Containing NH2-Terminal Sequences Of Types 5, 6, And 24 M Proteins Synthesized In Tandem," The Journal Of Experimental Medicine 166:647-656, 1987. Beachey et al., "Purification And Properties Of M Protein Extracted From Group A Streptococci With Pepsin: Covalent Structure Of The Amino Terminal Region Of Type 24 M Antigen," The Journal Of Experimental Medicine 145:1469-1483, 1977. Beachey et al., "Repeating Covalent Structure and Protective Immunogenicity of Native and Synthetic Polypeptide Fragments of Type 24 Streptococcal M Protein," The Journal Of Biological Chemistry 258(21):13250-13257, 1983. Beachey et al., "Repeating covalent structure of streptococcal M protein," Proc. Natl. Acad. Sci. USA 75(7):3163-3167, 1978. Beachey et al., "Separation Of The Type Specific M Protein From Toxic Cross Reactive Antigens Of Group A Streptococci," Transactions Of The Association Of American Physicians. Ninetieth Session vol. XC: pp. 390-400, 1977. Beachey et al., "Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M Protein," Nature (London) 292:457-459, 1981. Blenden et al., "Growth of Listeria monocytogenes in a Corn Silage Extract Medium," American Journal Of Veterinary Research 29(11):2237-2242, 1968. Bricas et al., "Structure Et Synthese De La Subunite Peptide De La Paroi De Trois Bacteries Gram-Postif," Peptides. Proceedings of the Eight European Peptide Symposium Sep. 1966, Noordwijk, Neth., North-Holland Publishing Company: Amsterdam, Neth. And Interscience Publishers Division, John Wiley and Sons, Inc., New York, 1967, 286-292 (+ Biological Abstracts 50(4):Abstract No. 20361, 1936). Bronze et al., "Protective And Heart-Cross Reactive Epitopes Located Within The NH2Terminus Of Type 19 Streptococcal M Protein," The Journal Of Experimental Medicine 167:1849-1859, 1988. Chou and Fasman, "Prediction of Protein Conformation," Biochemistry 13(2):222-245, 1974. Cunningham and Beachey, "Peptic Digestion of Streptococcal M Protein. I. Effect of Digestion at Suboptimal pH upon the Biological and Immunochemical Properties of Purified M Protein Extracts," Infection And Immunity 9(2):244-248, 1974. Cunningham et al., "Human And Murine Antibodies Cross-Reactive With Streptococcal M Protein And Myosin Recognize The Sequence Gln-Lys-Ser-Lys-Gln In M Protein," The Journal Of Immunology 143(8):2677-2683, 1989. Dale, "Group A Streptococcal Vaccines," New Vaccines And New Vaccine Technology 13(1):227-243, 1999. Dale, "Group A Streptococcal Vaccines," Pediatric Annals 27:301-308, 1998. Dale, "Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments," Vaccine 17:193-200, 1999. Dale and Beachey, "Epitopes Of Streptococcal M Proteins Shared With Cardiac Myosin," The Journal Of Experimental Medicine 162:583-591, 1985. Dale and Beachey, "Multiple, Heart-Cross-Reactive Epitopes Of Streptococcal M Proteins," Journal Of Experimental Medicine 161:113-122, 1985. Dale and Beachey, "Sequence Of Myosin-Crossreactive Epitopes Of Streptococcal M Protein," Journal Of Experimental Medicine 164:1785-1790, 1986. Dale and Beachey, "Localization Of Protective Epitopes Of The Amino Terminus Of Type 5 Streptococcal M Protein," The Journal Of Experimental Medicine 163:1191-1202, 1986. Dale et al., "Blastogenic Responses Of Human Lymphocytes To Structurally Defined Polypeptide Fragments Of Streptococcal M Protein," The Journal Of Immunology 126(4):1499-1505, 1981. Dale et al., "Heterogeneity Of Type-Specific And Cross-Reactive Antigenic Determinants Within A Single M Protein Of Group A Streptococci," The Journal Of Experimental Medicine 151:1026-1038, 1980. Dale et al., "Hyaluronate Capsule and Surface M Protein in Resistance to Opsonization of Group A Strep
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (12)
Varma Rajender S. (The Woodlands TX) Chiou George C. Y. (College Station TX), Arginine compounds as ocular hypotensive agents.
Ahluwalia Gurpreet S. (8632 Stable View Ct. Gaithersburg MD 20879) Shander Douglas (16112 Howard Landing Dr. Gaithersburg MD 20878) Henry James P. (6776 Wood Duck Ct. Frederick MD 21701), Reduction of hair growth.
Engelman E. Eric ; Schick Lynn ; Nair Mona ; Buch R. Michael, Stabilized antiplaque and antigingivitis oral compositions containing N.sup..alpha. -alkyl-L-arginine alkyl ester salts.
Quay, Steven C.; Houston, Jr., Michael E.; Harvie, Pierrot; Adami, Roger C.; Fam, Renata; Prieve, Mary G.; Fosnaugh, Kathy L.; Seth, Shaguna, Arginine-based lipids for delivery of therapeutics.
Vallance, Patrick John Thompson; Leiper, James Mitchell; Selwood, David Lawrence; Rossiter, Sharon; Hartzoulakis, Basil, Guanidine derivatives as inhibitors of DDAH.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.